Skip to main content
Fig. 6 | Biomarker Research

Fig. 6

From: Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse

Fig. 6

B leukemic cell heterogeneity. a UMAP representations of MC2 cells and heatmap of MC2 signature; b Comparison of ibrutinib-regulated B cell specific signatures in MC1 and MC2 cells; c UMAP representation of CXCR4, MIR155HG, CD5 and CD69 expression; d Fold change in cell number in MC1 and MC2 populations during ibrutinib treatment (compared to M0); e UMAP representation of differential signatures between MC1 and MC2 populations

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us